• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

19.17 +0.14 (+0.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
December 16, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
December 02, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
November 11, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
November 04, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
November 03, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
November 03, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
October 30, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
October 30, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 29, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Reports Third Quarter 2025 Financial Results
October 28, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 06, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Resignation of Board Member
September 18, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
September 05, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
August 01, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
July 29, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
July 29, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
July 28, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
July 22, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
June 25, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming EAACI Congress 2025
June 12, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
June 11, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
June 04, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
June 03, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Combined General Meeting of June 11, 2025
May 15, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025
May 06, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
May 05, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Reports First Quarter 2025 Financial Results
April 30, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
April 11, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
March 27, 2025
From DBV Technologies S.A.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap